F&P Healthcare warns of $5-10M hit in contesting latest Resmed patent allegations
-
font size
decrease font size
increase font size
Fisher & Paykel Healthcare expects the cost of contesting the latest patent allegations from rival ResMed will cut annual earnings by as much as $10 million in a far-ranging dispute across multiple jurisdictions